Skip to main content

View full-text article in PMC

. 2014 Oct 6;116(10):1301–1315. doi: 10.1002/ejlt.201400076

Table 6.

Summary of human dietary intervention studies: palm oil versus hydrogenated oils

Reference	Subjects (n)	Age (y)	BMI (kg/m2)	Design	Dietary fatty acids (%E)					Cholesterol (mg)	Lipids (mmol/L)
					Total fat	16:0	18:1t	18:1	18:2		TC	TAG	LDL-C	HDL-C
Teng et al. (2010)	33 female, 8 male completed	28.8 ± 9.1	21.9 ± 3.9	RCT, 5 wk, 1 wk washout	33.5	8.7	nd	15.3	5.8	<300	4.48	0.83	2.69	1.63
					32.3	8.1	9.9	7.2	3.9		4.72^*	0.89^*	3.11^*	1.42^*
					31.7	13.9	nd	10.7	3.6		4.66^*	0.88^*	2.95^*	1.55^*
Pedersen et al. (2005)	30 female, 27 completed	19–42	26.5 ± 4.1 (20–36)	RCT, 17 days, 1 wk washout	31.0	10.5	Nd	11.7	5.0	86	4.74	0.90	2.90	1.47
Pedersen et al. (2005)	30 female, 27 completed			RCT, 17 days, 1 wk washout	30.1	3.3	6.8	10.6	4.1	56	4.61	0.92	2.88	1.32
Sundram et al. (1997)	20 men, 9 women, 27 completed	19–39	22.7 ± 2.6	RCT, double-blind, 4 wk	31.7	11.4	nd	13.7	3.3	207	4.9	0.9	3.2	1.3
Sundram et al. (1997)	20 men, 9 women, 27 completed		(19–30)	RCT, double-blind, 4 wk	31.6	4.6	6.9	10.8	5.3	210	5.2^*	0.8	3.8^*	1.1
Nestel et al. (1992)	27 mildly hypercholes-terolemic men	46.8 ± 9.6	80.2 ± 8.9	RCT, 3 wk	37.0	9.8	<1	12.9	5.7	186	226	128	161	42
Nestel et al. (1992)	27 mildly hypercholes-terolemic men	(30–63)		RCT, 3 wk	37.0	4.9	5.7	11.3	6.6	168	229	142	165	38

Nd, not detectable.

^*

Significantly different from palm oil.